4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Gamma Hydroxybutyric Acid.
Abiraterone
The serum concentration of Trifluoperazine can be increased when it is combined with Abiraterone.
Acebutolol
Trifluoperazine may increase the hypotensive activities of Acebutolol.
Advertisement
Acepromazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Aceprometazine.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Trifluoperazine.
Advertisement
Alfaxalone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Trifluoperazine.
Almotriptan
The risk or severity of adverse effects can be increased when Almotriptan is combined with Trifluoperazine.
Advertisement
Alphaprodine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Trifluoperazine.
Alprenolol
Trifluoperazine may increase the hypotensive activities of Alprenolol.
Aluminum
Aluminium can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
aluminum hydroxide, dried (USP)
Aluminum hydroxide can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Magnesium Silicate
Almasilate can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Amantadine
The therapeutic efficacy of Trifluoperazine can be decreased when used in combination with Amantadine.
Amisulpride
Trifluoperazine may increase the antipsychotic activities of Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Amitriptyline.
Amobarbital
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Amobarbital.
Amodiaquine
The serum concentration of Trifluoperazine can be increased when it is combined with Amodiaquine.
Amoxapine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Amoxapine.
Amphetamine
Trifluoperazine may decrease the stimulatory activities of Amphetamine.
Apomorphine
The therapeutic efficacy of Trifluoperazine can be decreased when used in combination with Apomorphine.
Aripiprazole
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Aripiprazole.
Artemether
The serum concentration of Trifluoperazine can be increased when it is combined with Artemether.
Artesunate
The serum concentration of Trifluoperazine can be increased when it is combined with Artesunate.
Articaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Asenapine.
Atenolol
Trifluoperazine may increase the hypotensive activities of Atenolol.
Atovaquone
The serum concentration of Trifluoperazine can be increased when it is combined with Atovaquone.
Azelastine
Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azithromycin
The metabolism of Trifluoperazine can be decreased when combined with Azithromycin.
Baclofen
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Baclofen.
Barbital
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Barbital.
Benoxinate
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Benzocaine.
Benzphetamine
Trifluoperazine may decrease the stimulatory activities of Benzphetamine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Benzyl alcohol.
Betaxolol
Trifluoperazine may increase the hypotensive activities of Betaxolol.
Bismuth Subcitrate
Bismuth Subcitrate can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bisoprolol
Trifluoperazine may increase the hypotensive activities of Bisoprolol.
Bopindolol
Trifluoperazine may increase the hypotensive activities of Bopindolol.
Bortezomib
The metabolism of Trifluoperazine can be decreased when combined with Bortezomib.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Trifluoperazine.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Trifluoperazine.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Trifluoperazine.
Brexpiprazole
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.
Bromazepam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Bromazepam.
Bromocriptine
The therapeutic efficacy of Trifluoperazine can be decreased when used in combination with Bromocriptine.
Bromperidol
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Bupivacaine.
Bupranolol
Trifluoperazine may increase the hypotensive activities of Bupranolol.
Buprenorphine
Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Trifluoperazine.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Trifluoperazine.
Butalbital
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Butalbital.
Butamben
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Trifluoperazine.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Trifluoperazine.
Caffeine
The metabolism of Trifluoperazine can be decreased when combined with Caffeine.
Calcium Carbonate
Calcium Carbonate can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
CALCIUM CARBONATE, PRECIPITATED
Calcium Carbonate can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Trifluoperazine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Carbinoxamine.
Carisoprodol
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Carisoprodol.
Carteolol
Trifluoperazine may increase the hypotensive activities of Carteolol.
Carvedilol
Trifluoperazine may increase the hypotensive activities of Carvedilol.
Celiprolol
Trifluoperazine may increase the hypotensive activities of Celiprolol.
Cetirizine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Cetirizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Trifluoperazine.
Chlormethiazole
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Chloroprocaine.
Chloroquine
The serum concentration of Trifluoperazine can be increased when it is combined with Chloroquine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Chlorphenamine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Trifluoperazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Chlorzoxazone.
Citalopram
The metabolism of Trifluoperazine can be decreased when combined with Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Clidinium.
Clobazam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Clobazam.
Clomipramine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Clonidine.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Trifluoperazine.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Trifluoperazine.
Clotrimazole
The metabolism of Trifluoperazine can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Trifluoperazine.
Cocaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Trifluoperazine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Trifluoperazine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Trifluoperazine.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Trifluoperazine.
Cyclizine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Cyclobenzaprine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Cyproheptadine.
Cyproterone Acetate
The serum concentration of Trifluoperazine can be decreased when it is combined with Cyproterone acetate.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Trifluoperazine.
Dantrolene
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Dapiprazole.
Dapsone
The serum concentration of Trifluoperazine can be increased when it is combined with Dapsone.
Deferasirox
The serum concentration of Trifluoperazine can be increased when it is combined with Deferasirox.
Desflurane
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Desflurane.
Desipramine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Desloratadine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Desvenlafaxine.
Deutetrabenazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Deutetrabenazine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Dexbrompheniramine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Dexmedetomidine.
Dextroamphetamine
Trifluoperazine may decrease the stimulatory activities of Dextroamphetamine.
Dextromethorphan
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Trifluoperazine.
Dextromoramide
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Trifluoperazine.
Dibucaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Cinchocaine.
Diethylpropion
Trifluoperazine may decrease the stimulatory activities of Diethylpropion.
Difenoxin
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Dihydrocodeine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Trifluoperazine.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Dimenhydrinate.
Diphenhydramine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Diphenoxylate.
Dothiepin
The metabolism of Trifluoperazine can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Doxepin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Trifluoperazine.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Trifluoperazine.
Doxycycline
The serum concentration of Trifluoperazine can be increased when it is combined with Doxycycline.
Doxycycline Anhydrous
The serum concentration of Trifluoperazine can be increased when it is combined with Doxycycline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.
Duloxetine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Dyclonine.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Trifluoperazine.
Efavirenz
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Efavirenz.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Trifluoperazine.
Enflurane
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Entacapone.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Trifluoperazine.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Trifluoperazine.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Trifluoperazine.
Escitalopram
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Escitalopram.
Esmolol
Trifluoperazine may increase the hypotensive activities of Esmolol.
Estazolam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Estazolam.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Trifluoperazine.
Ethanol
Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Etomidate.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Trifluoperazine.
Ezogabine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Felbamate.
Fenfluramine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Fenfluramine.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Trifluoperazine.
Fexofenadine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Fexofenadine.
Flibanserin
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Flibanserin.
Flunarizine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Flunitrazepam.
Fluoxetine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Trifluoperazine.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Trifluoperazine.
Fluspirilene
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Fluticasone propionate.
Fluvoxamine
The metabolism of Trifluoperazine can be decreased when combined with Fluvoxamine.
Fosphenytoin
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Fospropofol.
Frovatriptan
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Trifluoperazine.
Gabapentin
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Gabapentin.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Gabapentin Enacarbil.
Glutethimide
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Halazepam.
Halofantrine
The serum concentration of Trifluoperazine can be increased when it is combined with Halofantrine.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Trifluoperazine.
Halothane
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Hexobarbital.
Hydrocodone
Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Trifluoperazine.
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hydroxychloroquine
The serum concentration of Trifluoperazine can be increased when it is combined with Hydroxychloroquine.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.
Iloperidone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Iloperidone.
Imipramine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Imipramine.
Isocarboxazid
The therapeutic efficacy of Trifluoperazine can be increased when used in combination with Isocarboxazid.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Trifluoperazine.
Ketamine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ketamine.
Ketazolam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ketazolam.
Labetalol
Trifluoperazine may increase the hypotensive activities of Labetalol.
Lamotrigine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Lamotrigine.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Trifluoperazine.
Levetiracetam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Levetiracetam.
Levobunolol
Trifluoperazine may increase the hypotensive activities of Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Levocetirizine.
Levodopa
The therapeutic efficacy of Trifluoperazine can be decreased when used in combination with Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Levorphanol.
Lidocaine
The metabolism of Trifluoperazine can be decreased when combined with Lidocaine.
Linezolid
The risk or severity of adverse effects can be increased when Linezolid is combined with Trifluoperazine.
Lisdexamfetamine
Trifluoperazine may decrease the stimulatory activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Trifluoperazine may decrease the stimulatory activities of Lisdexamfetamine.
Lithium
Lithium may increase the neurotoxic activities of Trifluoperazine.
Lithium Cation
Lithium may increase the neurotoxic activities of Trifluoperazine.
Loratadine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Trifluoperazine.
Lorcaserin
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Trifluoperazine.
Lormetazepam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Lormetazepam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Trifluoperazine.
Lumefantrine
The serum concentration of Trifluoperazine can be increased when it is combined with Lumefantrine.
Lurasidone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Lurasidone.
Magaldrate
Magaldrate can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide
Magnesium oxide can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Sulfate
The therapeutic efficacy of Trifluoperazine can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Trifluoperazine can be increased when used in combination with Magnesium sulfate.
Magnesium Trisilicate
Magnesium Trisilicate can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Maprotiline
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Maprotiline.
Meclizine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Meclizine.
Mefloquine
The serum concentration of Trifluoperazine can be increased when it is combined with Mefloquine.
Melatonin
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Trifluoperazine.
Mephentermine
Trifluoperazine may decrease the stimulatory activities of Mephentermine.
Mephobarbital
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Trifluoperazine.
Mequitazine
Trifluoperazine may increase the arrhythmogenic activities of Mequitazine.
Mesoridazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Metaxalone.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Trifluoperazine.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Methadyl Acetate.
Methamphetamine
Trifluoperazine may decrease the stimulatory activities of Methamphetamine.
Methapyrilene
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Methocarbamol.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Trifluoperazine.
Methotrimeprazine
Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Methsuximide.
Methylphenidate
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Methylphenidate.
Metipranolol
Trifluoperazine may increase the hypotensive activities of Metipranolol.
Metoclopramide
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Trifluoperazine.
Metoprolol
Trifluoperazine may increase the hypotensive activities of Metoprolol.
Metylperon
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Melperone.
Metyrosine
Trifluoperazine may increase the sedative activities of Metyrosine.
Mexiletine
The metabolism of Trifluoperazine can be decreased when combined with Mexiletine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Trifluoperazine.
Midostaurin
The metabolism of Trifluoperazine can be decreased when combined with Midostaurin.
Milnacipran
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.
Mirtazapine
Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Moclobemide
The risk or severity of adverse effects can be increased when Moclobemide is combined with Trifluoperazine.
Molindone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Trifluoperazine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.
Nadolol
Trifluoperazine may increase the hypotensive activities of Nadolol.
Nalbuphine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Nalbuphine.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Trifluoperazine.
Naratriptan
The risk or severity of adverse effects can be increased when Naratriptan is combined with Trifluoperazine.
Nebivolol
Trifluoperazine may increase the hypotensive activities of Nebivolol.
Nefazodone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Nefazodone.
Nevirapine
The metabolism of Trifluoperazine can be decreased when combined with Nevirapine.
Nitrazepam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Nitrazepam.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Nitrous oxide.
Norflurane
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Nortriptyline.
Olanzapine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Olanzapine.
Olopatadine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Olopatadine.
Ondansetron
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Opium.
Orphenadrine
Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Trifluoperazine can be decreased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Oxazepam.
Oxprenolol
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Trifluoperazine.
Oxymorphone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Oxymorphone.
p-Hydroxyamphetamine
Trifluoperazine may decrease the stimulatory activities of Hydroxyamphetamine.
Paliperidone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Paliperidone.
Paraldehyde
Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Trifluoperazine.
Paroxetine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Paroxetine.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Trifluoperazine.
Peginterferon Alfa-2b
The serum concentration of Trifluoperazine can be increased when it is combined with Peginterferon alfa-2b.
Penbutolol
Trifluoperazine may increase the hypotensive activities of Penbutolol.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Trifluoperazine.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Trifluoperazine.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.
Perazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Perphenazine.
Phenelzine
The risk or severity of adverse effects can be increased when Phenelzine is combined with Trifluoperazine.
Phenobarbital
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Phenoxyethanol.
Phentermine
Trifluoperazine may decrease the stimulatory activities of Phentermine.
PHENTERMINE RESIN
Trifluoperazine may decrease the stimulatory activities of Phentermine.
Phenytoin
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Pimozide.
Pindolol
Trifluoperazine may increase the hypotensive activities of Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Pipotiazine.
Piribedil
The therapeutic efficacy of Trifluoperazine can be decreased when used in combination with Piribedil.
Pirinitramide
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Pomalidomide.
Practolol
Trifluoperazine may increase the hypotensive activities of Practolol.
Pramipexole
Trifluoperazine may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Trifluoperazine can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Prilocaine.
Primaquine
The serum concentration of Trifluoperazine can be increased when it is combined with Primaquine.
Primidone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Procaine.
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Trifluoperazine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Trifluoperazine.
Proguanil
The serum concentration of Trifluoperazine can be increased when it is combined with Proguanil.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Trifluoperazine.
Promethazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Promethazine.
Proparacaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Trifluoperazine.
Propoxyphene
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Dextropropoxyphene.
Propranolol
Trifluoperazine may increase the hypotensive activities of Propranolol.
Protriptyline
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Protriptyline.
Pseudoephedrine
Trifluoperazine may decrease the stimulatory activities of Pseudoephedrine.
Pyrimethamine
The serum concentration of Trifluoperazine can be increased when it is combined with Pyrimethamine.
Quazepam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Quazepam.
Quetiapine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Quetiapine.
Quinacrine
The serum concentration of Trifluoperazine can be increased when it is combined with Quinacrine.
Quinagolide
The therapeutic efficacy of Quinagolide can be decreased when used in combination with Trifluoperazine.
Quinidine
The serum concentration of Trifluoperazine can be increased when it is combined with Quinidine.
Quinine
The serum concentration of Trifluoperazine can be increased when it is combined with Quinine.
Ramelteon
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ramelteon.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Trifluoperazine.
Rasagiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Trifluoperazine.
Remifentanil
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Remifentanil.
Remoxipride
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Trifluoperazine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Trifluoperazine.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Trifluoperazine.
Rizatriptan
The risk or severity of adverse effects can be increased when Rizatriptan is combined with Trifluoperazine.
Ropinirole
Trifluoperazine may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ropivacaine.
Rotigotine
Trifluoperazine may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Trifluoperazine can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Trifluoperazine.
Scopolamine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Scopolamine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Scopolamine.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Trifluoperazine.
Selegiline
The risk or severity of adverse effects can be increased when Selegiline is combined with Trifluoperazine.
Sertindole
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Sevoflurane.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Trifluoperazine.
Simeprevir
The metabolism of Trifluoperazine can be decreased when combined with Simeprevir.
Sodium Bicarbonate
Sodium bicarbonate can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.
Sotalol
Trifluoperazine may increase the hypotensive activities of Sotalol.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Trifluoperazine.
Sulfadoxine
The serum concentration of Trifluoperazine can be increased when it is combined with Sulfadoxine.
Sulfalene
The serum concentration of Trifluoperazine can be increased when it is combined with Sulfametopyrazine.
Sulpiride
Trifluoperazine may increase the antipsychotic activities of Sulpiride.
Sumatriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Trifluoperazine.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Trifluoperazine.
Suvorexant
Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Talinolol
Trifluoperazine may increase the hypotensive activities of Talinolol.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.
Tasimelteon
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Tasimelteon.
Tedizolid
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Trifluoperazine.
Tedizolid Phosphate
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Trifluoperazine.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Trifluoperazine.
Tenofovir Disoproxil
The metabolism of Trifluoperazine can be decreased when combined with Tenofovir disoproxil.
Teriflunomide
The serum concentration of Trifluoperazine can be decreased when it is combined with Teriflunomide.
Tetrabenazine
The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Trifluoperazine.
Tetracaine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.
Thalidomide
Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theophylline
The metabolism of Trifluoperazine can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Trifluoperazine can be decreased when combined with Theophylline.
Thiamylal
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Thiopental.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Trifluoperazine.
Thiothixene
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Thiothixene.
Tiagabine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Tiapride.
Ticlopidine
The metabolism of Trifluoperazine can be decreased when combined with Ticlopidine.
Timolol
Trifluoperazine may increase the hypotensive activities of Timolol.
Timolol Anhydrous
Trifluoperazine may increase the hypotensive activities of Timolol.
Tizanidine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Tizanidine.
Tolcapone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Tolcapone.
Topiramate
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Trifluoperazine.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Trifluoperazine.
Tranylcypromine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Triazolam.
Triazulenone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Loprazolam.
Triflupromazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Triflupromazine.
Trimethoprim
The serum concentration of Trifluoperazine can be increased when it is combined with Trimethoprim.
Trimipramine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Triprolidine.
Tromethamine
Tromethamine can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Urethane
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Valproic Acid.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Trifluoperazine.
Venlafaxine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Venlafaxine.
Vigabatrin
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Vigabatrin.
Vilazodone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Vilazodone.
Vincristine
The excretion of Vincristine can be decreased when combined with Trifluoperazine.
Vortioxetine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Vortioxetine.
Zaleplon
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Zaleplon.
Ziconotide
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Ziconotide.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Trifluoperazine.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Trifluoperazine.
Zolpidem
Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Zopiclone.
Zotepine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Zuclopenthixol.
